2023
DOI: 10.1016/j.ijbiomac.2023.125128
|View full text |Cite
|
Sign up to set email alerts
|

Biodegradable hydrogel from pectin and carboxymethyl cellulose with Silibinin loading for lung tumor therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 53 publications
0
5
0
Order By: Relevance
“…A prominent example was shown by Yin et al (2023) , who successfully created a biodegradable hydrogel by incorporating silibinin within a blend of pectin and OCMC. Silibinin, an agent with anti-lung cancer properties, selectively targets the TMEM16A ion channel.…”
Section: Pectin Hydrogel Applications In Drug Deliverymentioning
confidence: 99%
See 3 more Smart Citations
“…A prominent example was shown by Yin et al (2023) , who successfully created a biodegradable hydrogel by incorporating silibinin within a blend of pectin and OCMC. Silibinin, an agent with anti-lung cancer properties, selectively targets the TMEM16A ion channel.…”
Section: Pectin Hydrogel Applications In Drug Deliverymentioning
confidence: 99%
“…8 f, the group treated with hydrogel combined with silibinin (100 mg/kg) exhibited a notable tumor weight reduction, compared to the silibinin group (100 mg/kg), while the hydrogel combined with 200 mg/kg silibinin group displayed an even greater reduction in tumor weight. This hydrogel was rapidly formed and exhibited pH-sensitive sustained drug release owing to its acylhydrazone bond crosslinked networks, rendering it suitable for injectable use ( Yin et al, 2023 ).
Fig.
…”
Section: Pectin Hydrogel Applications In Drug Deliverymentioning
confidence: 99%
See 2 more Smart Citations
“…This method significantly enhanced the antitumor efficiency in vivo and greatly reduced the toxicity of Silibinin. [ 9 ] Jokerst et al. developed an injectable supramolecular hydrogel that can slow and track the release of doxorubicin (DOX) via photoacoustic tomography.…”
Section: Introductionmentioning
confidence: 99%